Veradermics, Inc. (MANE)
101.33
-3.37
(-3.22%)
USD |
NYSE |
May 22, 16:00
101.33
0.00 (0.00%)
After-Hours: 20:00
Veradermics Cash from Investing (Quarterly) : -101.30M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Organon & Co. | 386.00M |
| Merck & Co., Inc. | -10.21B |
| Bristol Myers Squibb Co. | -131.00M |
| Terns Pharmaceuticals, Inc. (DELISTED) | -350.00M |
| Corcept Therapeutics, Inc. | 4.542M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.17M |
| Cash from Financing (Quarterly) | 269.11M |
| Free Cash Flow Per Share (Quarterly) | -0.5669 |
| Free Cash Flow to Equity (Quarterly) | -21.16M |
| Free Cash Flow to Firm (Quarterly) | -21.17M |